Metagenomi Therapeutics
MGX · NASDAQ
$0.8313+$0.0195 (+2.40%)TodayMarket closed ·
Prev close $0.8118
Who owns MGX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 30.4% of MGX’s shares.
- Bayer HealthCare LLC10.8%
- Thomas (Brian C)6.4%
- Vanguard Capital Management, LLC2.9%
- Renaissance Technologies LLC2.0%
- Next 6 largest institutions8.4%
- All other shareholders69.6%
| Holder | Shares | % of shares |
|---|---|---|
| Bayer HealthCare LLC | 4.05M | 10.76% |
| Thomas (Brian C) | 2.40M | 6.37% |
| Vanguard Capital Management, LLC | 1.08M | 2.86% |
| Renaissance Technologies LLC | 742.40K | 1.97% |
| Irish (Jian) | 600.86K | 1.60% |
| Sozo Ventures LLC | 581.58K | 1.54% |
| Catalio Capital Management, LP | 528.99K | 1.41% |
| Two Sigma Investments, LP | 528.87K | 1.40% |
| Peapod Lane Capital LLC | 525.02K | 1.39% |
| Bridgeway Capital Management, LLC | 400.30K | 1.06% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 741.41K | 1.97% |
| Bridgeway Ultra-Small Company Fund | 327.10K | 0.87% |
| Vanguard Extended Market Index Fund | 315.46K | 0.84% |
| Fidelity Extended Market Index Fund | 136.44K | 0.36% |
| iShares Micro-Cap ETF | 96.73K | 0.26% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $23.40K (2 trades) and sold $14.43K (6 trades) of MGX on the open market.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Reid Laurence | Buy | 117 | $138 |
| Reid Laurence | Buy | 19.88K | $23.26K |
| Wein Matthew | Sale | 358 | $415 |
| Irish Jian | Sale | 2.14K | $2.48K |
| Wapnick Pamela | Sale | 1.91K | $2.21K |
| Eckhardt Juergen | Award | 21.00K | — |
| Reid Laurence | Award | 17.40K | — |
| Dere Willard H | Award | 21.00K | — |
| BJERKHOLT ERIC | Award | 21.00K | — |
| Wapnick Pamela | Sale | 2.88K | $3.75K |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.27M
- Days to cover
- 10.54
- % of shares outstanding
- 3.38%
- Average daily volume
- 120.63K
- Change since last report
- −11.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.